Fatty Acid Profiles and Their Association With Autoimmunity, Insulin Sensitivity and β Cell Function in Latent Autoimmune Diabetes in Adults

Huiqin Tian, Shiqi Wang, Yating Deng, Yanke Xing, Lin Zhao, Xia Zhang, Ping Zhang, Nan Liu, Benli SuFrontiers in Endocrinology 2022 · DOI

TL;DR

This study investigates the fatty acid (FA) profiles of individuals with Latent Autoimmune Diabetes in Adults (LADA) and compares them to Type 1 Diabetes (T1DM) and Type 2 Diabetes (T2DM) patients. The findings suggest that while FA profiles differ across diabetes types, LADA's FA profile is intermediate, and specific FA patterns are associated with autoimmunity, insulin sensitivity, and beta-cell function, offering potential insights into LADA's pathogenesis.

What Problem Does This Paper Address?

Latent Autoimmune Diabetes in Adults (LADA) is a complex subtype of diabetes characterized by a slow, progressive loss of beta-cell function, often presenting with features of both Type 1 and Type 2 diabetes. The exact pathogenesis of LADA remains elusive, making it challenging to differentiate from other diabetes types and to develop targeted treatment strategies. While autoantibodies like GADA are key diagnostic markers, understanding the underlying metabolic factors, such as dietary influences reflected in fatty acid profiles, could provide crucial insights into LADA's unique progression and its association with autoimmunity, insulin sensitivity, and beta-cell function. This paper aims to fill this gap by comprehensively analyzing the fatty acid profiles of LADA patients and exploring their correlations with these critical diabetes-related parameters.

Methods

The researchers employed a multi-faceted approach:

  • Patient Classification: Patients were classified into T1DM, LADA, and T2DM based on age of onset, GADA positivity, and residual C-peptide levels. T2DM patients were matched to LADA and T1DM patients using Propensity Score Matching.
  • Fatty Acid Analysis: Fatty acid profiles were determined using liquid chromatography-tandem mass spectrometry (LC-MS/MS).
  • Statistical Analysis:
    • Principal Factor Analysis (PCA): Used to identify underlying dietary patterns or metabolic components from the complex FA data.
  • ANOVA: Employed to compare FA levels across the different diabetes groups.
  • Heatmap Analysis: Visualized the correlations between specific fatty acids and diabetes types.
  • Spearman Correlation: Used to assess the association between FA profiles and autoimmunity markers (GADA, ATG, ATPO), insulin sensitivity, and beta-cell function.
  • K-means Clustering: Applied to group patients based on their FA profiles to explore potential relationships with clinical characteristics.

Datasets

The study utilized data from:

  • 116 GADA-positive patients (classified as LADA or T1DM).
  • 249 GADA-negative patients (classified as T2DM), selected via Propensity Score Matching from a larger cohort of 848 T2DM patients.

No new benchmarks were introduced; the study relied on existing clinical data and diagnostic criteria for diabetes classification.

Key Insights and Ideas

  • LADA as an Intermediate Phenotype: The FA profile of LADA patients appears to be intermediate between T1DM and T2DM, reinforcing the idea of LADA as a hybrid form of diabetes.
  • Dietary Patterns and FA Profiles: PCA revealed distinct dietary patterns influencing FA profiles, including those associated with lard oil, seafood, vegetable oil, and high-fat diets. This highlights the significant role of diet in shaping the metabolic landscape of diabetes.
  • Specific FAs Linked to Autoimmunity: Certain fatty acids, particularly n-3 PUFAs (like ALA, EPA, DHA) and the n-3/n-6 ratio, were negatively associated with GADA positivity, suggesting a potential protective role. Conversely, n-6 Arachidonic Acid showed a positive association.
  • FAs and Metabolic Function: Similar FA associations were observed with insulin sensitivity and beta-cell function, indicating that dietary fat composition might directly influence these critical aspects of glucose homeostasis.
  • Clustering Reveals Subgroups: Clustering patients by FA profiles identified subgroups with distinct clinical characteristics, including variations in BMI, blood pressure, and glycemic control, suggesting that FA composition might stratify diabetes risk or progression within broader diagnostic categories.

Key Results

  • FA Differences Across Diabetes Types: T2DM patients showed higher levels of n-3 LC-PUFAs, n-3/n-6 ratio, and triene/tetraene ratio, and lower levels of saturated FAs and n-6 LC-PUFAs compared to LADA and T1DM.
  • Heatmap Distinctions: Heatmap analysis clearly differentiated the FA profiles of the three diabetes groups, with LADA showing an intermediate pattern.
  • Clustering Insights:
    • Cluster 5, enriched with T1DM and LADA patients, showed an insulin-deficient phenotype.
  • Cluster 3, primarily T2DM patients, exhibited better beta-cell function and glycemic control.
  • Cluster 2, with a majority of T2DM patients but also a significant proportion of T1DM and LADA, showed mixed characteristics.
  • Correlation Findings:
    • n-3 linolenic acid, n-3 LC-PUFAs, and the n-3/n-6 ratio were negatively associated with GADA positivity, insulin sensitivity, and beta-cell function.
  • n-6 Arachidonic Acid was positively associated with GADA positivity.
  • Saturated fatty acids and AOA (C20:4 n-6) were positively associated with GADA and thyroid autoimmunity, while MUFA, n-3 PUFA, and the n-3/n-6 ratio were negatively associated.

Limitations and Future Work

The authors acknowledge several limitations:

  • Retrospective Design: The study was retrospective, relying on existing clinical data.
  • Limited Autoantibody Data: Only GADA was used for LADA diagnosis, potentially missing other relevant autoantibodies.
  • Empirical Insulin Therapy: The timing of insulin therapy initiation was not recorded and was largely empirical, which could influence metabolic parameters.
  • Confounding Factors: The use of antidiabetic agents and statins was not adjusted for, although previous studies suggest minimal impact.
  • Small Sample Sizes in Clusters: Some identified FA clusters had insufficient patient numbers for robust analysis.

Future work should focus on:

  • Well-designed clinical trials: To further delineate the role of PUFAs in preventing or slowing beta-cell deterioration in LADA.
  • Investigating specific PUFA ratios: More research is needed to understand the precise impact of n-3/n-6 ratios and triene/tetraene ratios.
  • Exploring other autoantibodies: Including a broader range of autoantibodies in LADA diagnosis and analysis.
  • Prospective studies: To establish causal relationships and track the progression of LADA in relation to FA profiles.

Summary updated

Abstract

none.
BibTeX
@inproceedings{tian2022fatty,
  author = {Huiqin Tian and Shiqi Wang and Yating Deng and Yanke Xing and Lin Zhao and Xia Zhang and Ping Zhang and Nan Liu and Benli Su},
  title = {{Fatty Acid Profiles and Their Association With Autoimmunity, Insulin Sensitivity and β Cell Function in Latent Autoimmune Diabetes in Adults}},
  booktitle = {Frontiers in Endocrinology},
  year = {2022},
  doi = {10.3389/fendo.2022.916981},
}
Figure